PE20100053A1 - Compuestos heterociclicos como inhibidores de la adn girasa - Google Patents
Compuestos heterociclicos como inhibidores de la adn girasaInfo
- Publication number
- PE20100053A1 PE20100053A1 PE2009000778A PE2009000778A PE20100053A1 PE 20100053 A1 PE20100053 A1 PE 20100053A1 PE 2009000778 A PE2009000778 A PE 2009000778A PE 2009000778 A PE2009000778 A PE 2009000778A PE 20100053 A1 PE20100053 A1 PE 20100053A1
- Authority
- PE
- Peru
- Prior art keywords
- girase
- inhibitors
- alyl
- pyridin
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A COMPUESTOS HETEROCICLICOS DE FORMULA (I) DONDE Y ES S U O; Q ES C(=O)NR4, C(=S)NR5, C(=O)O, ENTRE OTROS, DONDE R4 Y R5 SON CADA UNO H, OH, ALQUIL(C1-C4) O CICLOALQUIL(C3-C6); R1 ES ALQUIL(C1-C6), ALQUENIL(C2-C6), ALQUINIL(C2-C6), ALCOXI(C1-C6), ENTRE OTROS; X ES N O CRa, DONDE Ra ES H, F, CH3, ENTRE OTROS; m ES DE 0 A 5; A ES UN SISTEMA DE ANILLOS CARBOCICLICO O HETEROCICLICO DE HASTA 12 ATOMOS; R3 ES H, HALO, NITRO, CN, ENTRE OTROS; R2 ES H, ALQUIL(C1-C6), ALQUENIL(C2-C6), ALCOXI(C1-C6), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 1-ALIL-3-(6-CLORO-TIAZOLO[5,4-b]PIRIDIN-2-IL)-UREA, 1-ALIL-3-(6-BROMO-5-METIL-TIAZOLO[5,4-b]PIRIDIN-2-IL)-UREA, 5-[2-(3-ALIL-UREIDO)-5-METIL-TIAZOLO[5,4-b]PIRIDIN-6-IL]-N,N-DIMETIL-NICOTINAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA ADN GIRASA BACTERIANA SIENDO UTILES EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5874808P | 2008-06-04 | 2008-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20100053A1 true PE20100053A1 (es) | 2010-02-25 |
Family
ID=40872366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2009000778A PE20100053A1 (es) | 2008-06-04 | 2009-06-04 | Compuestos heterociclicos como inhibidores de la adn girasa |
Country Status (16)
Country | Link |
---|---|
US (1) | US20100137303A1 (es) |
EP (1) | EP2303894A1 (es) |
JP (1) | JP2011522024A (es) |
KR (1) | KR20110031419A (es) |
CN (1) | CN102056932A (es) |
AR (1) | AR072047A1 (es) |
AU (1) | AU2009254928A1 (es) |
BR (1) | BRPI0913300A2 (es) |
CA (1) | CA2725689A1 (es) |
CL (1) | CL2009001346A1 (es) |
MX (1) | MX2010013249A (es) |
PE (1) | PE20100053A1 (es) |
RU (1) | RU2010154499A (es) |
TW (1) | TW201002723A (es) |
UY (1) | UY31860A (es) |
WO (1) | WO2009147431A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10532989B2 (en) | 2007-05-09 | 2020-01-14 | Shell Oil Company | Epoxidation catalyst, a process for preparing the catalyst, and a process for the production of an olefin oxide, a 1,2-diol, a 1,2-diol ether, a 1,2-carbonate, or an alkanolamine |
WO2011121555A1 (en) | 2010-03-31 | 2011-10-06 | Actelion Pharmaceuticals Ltd | Antibacterial isoquinolin-3-ylurea derivatives |
NZ608069A (en) | 2010-10-06 | 2014-06-27 | Glaxosmithkline Llc | Benzimidazole derivatives as pi3 kinase inhibitors |
AR088729A1 (es) | 2011-03-29 | 2014-07-02 | Actelion Pharmaceuticals Ltd | Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica |
CN103702994B (zh) * | 2011-06-20 | 2016-03-23 | 沃泰克斯药物股份有限公司 | 旋转酶和拓扑异构酶抑制剂的磷酸酯 |
JP2015514063A (ja) * | 2012-03-22 | 2015-05-18 | ビオタ ヨーロッパ リミテッドBiota Europe Ltd | 抗菌化合物 |
KR102178590B1 (ko) * | 2012-07-18 | 2020-11-13 | 유니버시티 오브 노트르 담 듀락 | 5,5-헤테로방향족 항-감염 화합물 |
KR101602559B1 (ko) * | 2014-04-29 | 2016-03-10 | 경북대학교 산학협력단 | 2,5,6,7-사중치환 티아졸로[4,5-b]피리딘 유도체 및 이의 용도 |
CN104788473B (zh) * | 2015-03-25 | 2017-03-15 | 石家庄学院 | 一种具有抗菌能力的化合物及其制备方法与用途 |
CN104744493B (zh) * | 2015-04-08 | 2017-01-25 | 石家庄学院 | 3‑苯甲酰基‑5,7‑二苯基‑5H‑噻唑并[3,2‑a]嘧啶类衍生物及其应用 |
ES2837396T3 (es) | 2016-11-23 | 2021-06-30 | Bayer Cropscience Ag | Derivados de 2-[3-(alquilsulfonil)-2H-indazol-2-il]-3H-imidazo[4,5-b]piridina y compuestos similares como pesticidas |
US20210070747A1 (en) | 2017-03-24 | 2021-03-11 | Taisho Pharmaceutical Co., Ltd. | 2(1h)-quinolinone derivative |
CN110709386B (zh) | 2017-03-30 | 2022-06-07 | 凯瑞康宁生物工程(武汉)有限公司 | 双环杂芳基衍生物及其制备与用途 |
EP3847172A1 (en) | 2018-09-03 | 2021-07-14 | Univerza v Ljubljani | New class of dna gyrase and/or topoisomerase iv inhibitors with activity against gram-positive and gram-negative bacteria |
WO2022129327A1 (en) | 2020-12-17 | 2022-06-23 | Univerza V Ljubljani | New n-phenylpyrrolamide inhibitors of dna gyrase and topoisomerase iv with antibacterial activity |
WO2022165198A1 (en) * | 2021-01-29 | 2022-08-04 | Board Of Trustees Of Michigan State University | Therapeutic compounds and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1341769T3 (da) * | 2000-12-15 | 2008-01-28 | Vertex Pharma | Bakterielle gyrase-inhibitorer og anvendelser deraf |
KR20060079098A (ko) * | 2004-12-31 | 2006-07-05 | 주식회사 엘지생명과학 | 신규한([1,3]티아졸로[5,4-b]피리딘-2-일)-2-카르복사마이드유도체 |
GB0724342D0 (en) * | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
MX2010011370A (es) * | 2008-04-16 | 2010-12-15 | Vertex Pharma | Inhibidores de fosfatidilinositol 3-cinasa. |
-
2009
- 2009-06-02 MX MX2010013249A patent/MX2010013249A/es not_active Application Discontinuation
- 2009-06-02 RU RU2010154499/04A patent/RU2010154499A/ru not_active Application Discontinuation
- 2009-06-02 WO PCT/GB2009/050609 patent/WO2009147431A1/en active Application Filing
- 2009-06-02 US US12/476,418 patent/US20100137303A1/en not_active Abandoned
- 2009-06-02 AU AU2009254928A patent/AU2009254928A1/en not_active Abandoned
- 2009-06-02 BR BRPI0913300A patent/BRPI0913300A2/pt not_active IP Right Cessation
- 2009-06-02 CN CN2009801213159A patent/CN102056932A/zh active Pending
- 2009-06-02 KR KR1020107027269A patent/KR20110031419A/ko not_active Application Discontinuation
- 2009-06-02 EP EP09757803A patent/EP2303894A1/en not_active Withdrawn
- 2009-06-02 JP JP2011512214A patent/JP2011522024A/ja active Pending
- 2009-06-02 CA CA2725689A patent/CA2725689A1/en not_active Abandoned
- 2009-06-03 TW TW098118460A patent/TW201002723A/zh unknown
- 2009-06-03 CL CL2009001346A patent/CL2009001346A1/es unknown
- 2009-06-03 UY UY0001031860A patent/UY31860A/es unknown
- 2009-06-04 PE PE2009000778A patent/PE20100053A1/es not_active Application Discontinuation
- 2009-06-04 AR ARP090102014A patent/AR072047A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX2010013249A (es) | 2010-12-21 |
WO2009147431A1 (en) | 2009-12-10 |
UY31860A (es) | 2010-01-29 |
EP2303894A1 (en) | 2011-04-06 |
RU2010154499A (ru) | 2012-07-20 |
TW201002723A (en) | 2010-01-16 |
CN102056932A (zh) | 2011-05-11 |
BRPI0913300A2 (pt) | 2018-05-22 |
AU2009254928A1 (en) | 2009-12-10 |
CA2725689A1 (en) | 2009-12-10 |
CL2009001346A1 (es) | 2010-07-02 |
JP2011522024A (ja) | 2011-07-28 |
AR072047A1 (es) | 2010-08-04 |
US20100137303A1 (en) | 2010-06-03 |
KR20110031419A (ko) | 2011-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20100053A1 (es) | Compuestos heterociclicos como inhibidores de la adn girasa | |
PE20081836A1 (es) | Derivados de piperidina como inhibidores de la sintasa de acido graso | |
PE20130385A1 (es) | Derivados del acido naft-2-ilacetico para tratar el sida | |
PE20090238A1 (es) | Derivados de pirazol como inhibidores de tirosinquinasas | |
PE20091573A1 (es) | Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa | |
PE20080608A1 (es) | Compuestos quimicos | |
ECSP099461A (es) | Compuesto heteromonocíclico y uso del mismo | |
PE20070946A1 (es) | COMPUESTOS DERIVADOS DE IMIDAZO[1,2-a]PIRIDINA COMO MODULADORES DEL RECEPTOR DE QUIMIOQUINA (CXCR4) | |
AR074608A1 (es) | Derivados de 2-(piperidin-1-il)-4-heterociclil-tiazol-5-carboxilico para infecciones bacterianas | |
PE20081753A1 (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal | |
PE20171341A1 (es) | Compuestos de pirazina para el tratamiento de enfermedades infecciosas | |
PE20141558A1 (es) | Derivados de acido benzotiazol-6-il acetico y su uso para tratar una infeccion por vih | |
PE20091561A1 (es) | Compuestos inhibidores de raf y metodos para su uso | |
PE20090601A1 (es) | Derivados de piridin-il-oxi-piridinas como inhibidores de alk5 | |
PE20091466A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il-amina | |
PE20161371A1 (es) | Compuestos organicos de monobactam para el tratamiento de infecciones bacterianas | |
AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
PE20120693A1 (es) | Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2) | |
PE20121506A1 (es) | Compuestos triazolopiridinas como inhibidores de c-met | |
PE20142164A1 (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
PE20130339A1 (es) | Compuestos heterociclicos y sus usos | |
PE20080552A1 (es) | Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasa | |
PE20090813A1 (es) | Inhibidores de la 11b-hidroxiesteroide-deshidrogenasa | |
PE20140011A1 (es) | Compuestos y composiciones novedosos para la inhibicion de nampt | |
PE20130149A1 (es) | Derivados de la cromenona con actividad anti-tumoral |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |